415 related articles for article (PubMed ID: 19553400)
21. [To further improve the effects of surgical treatment for hilar cholangiocarcinoma].
Chen XP; Huang ZY
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1121-2. PubMed ID: 20021897
[No Abstract] [Full Text] [Related]
22. Management and extent of resection for intrahepatic cholangiocarcinoma.
Carpizo DR; D'Angelica M
Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813
[TBL] [Abstract][Full Text] [Related]
23. [Mucin hypersecreting cholangiocarcinoma].
Jeen YM; Jin SY
Korean J Hepatol; 2008 Dec; 14(4):532-6. PubMed ID: 19119249
[No Abstract] [Full Text] [Related]
24. Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas.
Hayashi H; Maeda T; Adachi E; Shimada M; Matsumata T; Takenaka K
Hepatogastroenterology; 1995; 42(5):440-4. PubMed ID: 8751192
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
26. Distal cholangiocarcinoma.
Liu K
J Surg Oncol; 2007 Mar; 95(3):192-3. PubMed ID: 17323332
[No Abstract] [Full Text] [Related]
27. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
Lee CT; Wu TT; Lohse CM; Zhang L
Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
[TBL] [Abstract][Full Text] [Related]
28. [Comment on "Management of hilar cholangiocarcinoma"].
Launois B
J Chir (Paris); 2009 Feb; 146(1):101-2. PubMed ID: 19446704
[No Abstract] [Full Text] [Related]
29. Hilar cholangiocarcinoma and liver transplantation.
Heimbach J
Transplantation; 2009 Aug; 88(3):299-300. PubMed ID: 19667928
[No Abstract] [Full Text] [Related]
30. Recurrence of intrahepatic cholangiocarcinoma nine years after surgical resection.
Kitagawa D; Taketomi A; Aishima S; Kuroda Y; Gion T; Shirabe K; Shimada M; Maehara Y
Hepatogastroenterology; 2008; 55(84):1085-8. PubMed ID: 18705334
[TBL] [Abstract][Full Text] [Related]
31. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
[TBL] [Abstract][Full Text] [Related]
32. Total necrosis of rapid growing hilar cholangiocarcinoma.
Cha IH; Kim JN; Oh MK; Ryu SH; Kim YS; Moon JS; Lee HK
Gastrointest Endosc; 2013 Jun; 77(6):956-7; discussion 957-8. PubMed ID: 23522022
[No Abstract] [Full Text] [Related]
33. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
34. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
35. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.
Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Kondo Y; Miyazaki M
Am J Surg Pathol; 2011 Apr; 35(4):512-21. PubMed ID: 21412069
[TBL] [Abstract][Full Text] [Related]
36. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
Zhao SM; Zhu XZ; Ji Y; Hou J
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
[TBL] [Abstract][Full Text] [Related]
37. [Liver resection (part I) -- anatomical basis, indication, and preoperative planning].
Oldhafer KJ; Bourquain H; Stavrou GA
Zentralbl Chir; 2006 Apr; 131(2):W22-33; W34-5. PubMed ID: 16612771
[No Abstract] [Full Text] [Related]
38. Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: value of percutaneous transhepatic biliary drainage and cholangioscopy.
Sakamoto E; Hayakawa N; Kamiya J; Kondo S; Nagino M; Kanai M; Miyachi M; Uesaka K; Nimura Y
World J Surg; 1999 Oct; 23(10):1038-43; discussion 1043-4. PubMed ID: 10512944
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
Zimmerman RL; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
[TBL] [Abstract][Full Text] [Related]
40. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
